Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of systemically administered mutant vesicular stomatitis virus (VSVDelta51) combined with radiation for nasopharyngeal carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Aug 2008

Alajez Nehad M, Mocanu Joseph D, Shi Wei, Chia Marie C, Breitbach Caroline J, Hui Angela B Y, Knowles Shane, Bell John C, Busson Pierre, Takada Kenzo, Lo Kwok-Wai, O'Sullivan Brian, Gullane Pat, Liu Fei-Fei

Abstract excerpt

PURPOSE: Nasopharyngeal carcinoma (NPC) is a malignancy of the head and neck region that is associated with EBV latency. Curative treatments for NPC achieve modest survival rates, underscoring a need to develop novel therapies. We evaluated the therapeutic potential of a mutant vesicular stomatit...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Carcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Survival

Share to Combined Modality Therapy

Share to Mice, Nude

Share to Nasopharyngeal Neoplasms

Share to Neoplasm Transplantation

Share to Treatment Outcome

Source

Identifiers

PMID: 18676763
DOI: 10.1158/1078-0432.CCR-07-4134

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-18676763-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy of systemically administered mutant vesicular stomatitis virus (VSVDelta51) combined with radiation for nasopharyngeal carcinoma.PMID 18676763Read ↗

Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancerSemantic proximity Read ↗

Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Histone Deacetylase Inhibitors Potentiate Vesicular Stomatitis Virus Oncolysis in Prostate Cancer Cells by Modulating NF-κB-Dependent AutophagySemantic proximity Read ↗

Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysisSemantic proximity Read ↗

Oncolytic Activity of Vesicular Stomatitis Virus Is Effective against Tumors Exhibiting Aberrant p53, Ras, or Myc Function and Involves the Induction of ApoptosisSemantic proximity Read ↗

Oncolytic vesicular stomatitis virus as a treatment for neuroendocrine tumors.Semantic proximity Read ↗

Replicative oncolytic herpes simplex viruses in combination cancer therapies.Semantic proximity Read ↗

Fusogenic vesicular stomatitis virus for the treatment of head and neck squamous carcinomas.Semantic proximity Read ↗

Investigational drugs for nasopharyngeal carcinoma.Semantic proximity Read ↗

Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironment.Semantic proximity Read ↗

Silver nanoparticles selectively induce human oncogenic γ-herpesvirus-related cancer cell death through reactivating viral lytic replicationSemantic proximity Read ↗

Oncolytic activity of a coxsackievirus B3 strain in patient-derived cervical squamous cell carcinoma organoids and synergistic effect with paclitaxelSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.